Ju Hyun Kim
Overview
Explore the profile of Ju Hyun Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
1365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Hong W, Kang H, Kim J, Lee D, Cheong J, et al.
Cell Death Dis
. 2025 Mar;
16(1):161.
PMID: 40055335
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer with poor prognosis, largely due to the rapid development of chemoresistance in patients. Mitochondrial dynamics play a crucial role in cancer...
2.
Shin S, Mishima Y, Lee Y, Kwon O, Kim J, Kim Y, et al.
J Gastroenterol Hepatol
. 2025 Jan;
PMID: 39865534
Adoptive cell therapy (ACT) is a type of immunotherapy in which autologous or allogeneic immune cells, such as tumor-infiltrating lymphocytes or engineered lymphocytes, are infused into patients with cancer to...
3.
Kang J, Kim D, Yoo J, Shin J, Kim J, Lee J, et al.
Food Sci Biotechnol
. 2024 Nov;
33(15):3629-3637.
PMID: 39493388
Oxidative stress in skeletal muscle can lead to muscle atrophy through reactive oxygen species (ROS)-induced damage and cell death. -Butyl hydroperoxide (TBHP), an exogenous ROS generator, induces oxidative stress and...
4.
Kang W, Kim Y, Kim S, Seo Y, Kim J, Kim J, et al.
Future Oncol
. 2024 Sep;
20(37):2949-2959.
PMID: 39320906
This post-marketing surveillance study evaluated the safety and effectiveness of lenvatinib as first-line treatment for unresectable hepatocellular carcinoma in Korea. Adverse drug reactions (ADRs) and other safety and effectiveness end...
5.
Kim Y, Kim J
Chem Rec
. 2024 Aug;
24(9):e202400067.
PMID: 39166700
Pd-catalyzed stereoselective glycosylations using unsaturated sugar derivatives, glycals, have been successfully achieved in recent years. This review focuses on approaches to control the stereoselectivities of glycosides via π-allyl intermediates that...
6.
Yoon S, Kim J, Lee H, Kim K
Hip Pelvis
. 2023 Dec;
35(4):238-245.
PMID: 38125268
Purpose: Elderly patients with degenerative diseases undergo treatment for the hip and spine; these patients present with various symptoms. This study focused on patients with residual symptoms, predominantly pain, even...
7.
Cho H, Kim J
Org Biomol Chem
. 2023 Nov;
21(48):9507-9518.
PMID: 38009204
Transition metal-catalyzed dipolar cycloaddition is one of the most efficient and powerful synthetic strategies to produce diverse heterocycles. In particular, for the construction of oxygen-containing heterocycles, which are valuable structural...
8.
Suh J, Jang H, Kim K, Kim J, Choi S, Kim K, et al.
J Orthop Sci
. 2023 Nov;
29(6):1423-1429.
PMID: 37953191
Background: Various operative methods for the treatment of Morton's neuroma have been discussed, and osteotomy of the metatarsal bone has been reported recently. However, there has been no report of...
9.
Kang H, Kim J, Lee D, Lee Y, Kim M, Kim H, et al.
Cancer Biol Ther
. 2023 Nov;
24(1):2272334.
PMID: 37917550
Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer with high morbidity and mortality rates worldwide. Owing to a lack of therapeutic options, the overall survival rate of patients with...
10.
Kim M, Kim H, Kang H, Lee D, Hong W, Kim J, et al.
Cells
. 2023 Oct;
12(20).
PMID: 37887353
Pancreatic cancer is characterized by a poor prognosis, with its five-year survival rate lower than that of any other cancer type. Gemcitabine, a standard treatment for pancreatic cancer, often has...